NEW YORK (GenomeWeb) – The Perelman School of Medicine at the University of Pennsylvania has received a $7.3 million grant from the National Cancer Institute for three research projects targeting genes and proteins involved in of esophageal cancer.

The grant renews an NCI-funded program at the Perelman school that has been ongoing for 10 years, and is the only program of its kind that NCI supports that is focused on finding treatments and biomarkers for esophageal cancer, the medical school said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.